https://doi.org/10.1007/s00392-025-02625-4
1LMU Klinikum der Universität München Medizinische Klinik und Poliklinik I München, Deutschland; 2University Hospital Munich Division of Pediatric Cardiology and Intensive Care Medicine München, Deutschland; 3LMU Klinikum der Universität München Herzchirurgische Klinik und Poliklinik München, Deutschland; 4LMU Klinikum der Universität München Klinik für Anästhesiologie München, Deutschland; 5University Hospital, LMU Munich Department of Obstetrics and Gynecology München, Deutschland; 6LMU Klinikum der Universität München Med. Klinik u. Poliklinik, Interventionelle Elektrophysiologie München, Deutschland
Background:
Maternal mortality during pregnancy, delivery and postpartum is still of relevance and even increasing following changes in maternal demography, as women are getting pregnant at an older age, tend to present with more cardiovascular risk factors and cardiovascular diseases. Moreover, therapy of congenital heart disease improved dramatically, leading to more women survived in good condition to an age where aim for motherhood becomes present.
Purpose:
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy recommend implementation of a multidisciplinary Pregnancy Heart Team for treatment of high-risk patient. Data on clinical real world experiences of those are missing. The aim of this study was to present 10 year experience of interdisciplinary treatment in a Pregnancy Heart Team in a high volume center.
Methods:
All patients treated by the pregnancy heart team 2014 until 2023 were included into this retrospective analysis. We analyzed the number of patients, distribution over time and admitting department of the clinic. Baseline characteristics of the patients were collected, as well as details concerning delivery and postpartum period.
Results:
Over 200 patients were included into our analysis and patient number increased during the last 10 years (Figure 1). Most patients were treated due to valvular heart disease, followed by primary electric genetic heart disease, as well as Cardiomyopathies and arrhythmias (Figure 2).
Conclusions:
As suspected, patients number raised of the last 10 years. Most of the recommendations are focused on EMAH patients. Surprisingly, a large proportion of women in our cohort suffered from non-congenital heart disease. The heart pregnancy team in action helps to structure processes, responsibilities and decision making. With clear structures high risk patients can be identified electively and emergency decisions might be avoided.